학술논문

A Case of Intraductal Papillary Mucinous Neoplasm-Derived Pancreatic Adenosquamous Cell Carcinoma in Residual Pancreas Five Years after Surgery for Intraductal Papillary Mucinous Adenocarcinoma / 膵管内乳頭粘液性腺癌術後5年目に残膵発症したIPMN由来膵腺扁平上皮癌の1例
Document Type
Journal Article
Source
日本臨床外科学会雑誌 / Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association). 2020, 81(9):1883
Subject
adenosquamous carcinoma
intraductal papillary mucinous neoplasm
recurrence
再発
腺扁平上皮癌
膵管内乳頭粘液性腫瘍
Language
Japanese
ISSN
1345-2843
1882-5133
Abstract
This case involved a 68-year-old woman who had undergone pancreatoduodenectomy for an intraductal papillary mucinous neoplasm (IPMN) in the head of the pancreas. On histopathological examination, the diagnosis was invasive intraductal papillary mucinous carcinoma (IPMC), pT1N0M0, pStage I. The intraductal papillary mucinous adenoma was widely observed in the branched pancreatic duct of the resected specimen. The patient received S-1 as adjuvant chemotherapy. Five years after surgery, enhanced abdominal CT and MRI showed a 35-mm-sized mass lesion in the residual pancreas. FDG-PET showed strong FDG uptake in the mass, but there was no evidence of metastasis. Total residual pancreatectomy was then performed. Histopathological examination showed that the tumor was composed of adenocarcinoma and squamous cell carcinoma. Proliferation of atypical cells considered to be IPMC was observed in the expanded main pancreatic duct, and transition to both adenocarcinoma and squamous cell carcinoma was observed. The tumor was therefore diagnosed as IPMN-derived adenosquamous carcinoma (ASC). Only six cases of IPMN-derived pancreatic ASC have been reported, and the present case is the first report of pancreatic ASC in the residual pancreas after IPMC resection.